- 同花顺特色产品
- 〈高级诊股〉 全方位深度分析，提供明确投资建议
- 短期趋势：
短期行情可能回暖，可适量买进股票，作短线反弹行情。
- 中期趋势：
下跌有所减缓，仍应保持谨慎。
- 长期趋势：
已有40家主力机构披露2025-06-30报告期持股数据，持仓量总计1.87亿股，占流通A股46.53%
- 波段诊断：
-
技术面诊股
诊断结果：4.0技术面打败了8%的股票
技术面评分前10的股票
近期的平均成本为8.55元。空头行情中，目前反弹趋势有所减缓，投资者可适当关注。
平均成本
近期的平均成本为8.55元。
[{"text":"\u5e73\u5747\u6210\u672c","value":"8.55","date":1774339671,"color":"0x9f0ba1"}]
市场表现
过去10个交易日，该股走势跑输大盘，跑输行业平均水平。
[{"date":"2026.03.25","stock":"-0.58","trade":null,"ind":"1.95"},{"date":"2026.03.24","stock":"5.95","trade":null,"ind":"1.43"},{"date":"2026.03.23","stock":"-8.19","trade":null,"ind":"-3.76"},{"date":"2026.03.20","stock":"-4.66","trade":null,"ind":"-0.25"},{"date":"2026.03.19","stock":"-2.95","trade":null,"ind":"-2.02"},{"date":"2026.03.18","stock":"2.15","trade":null,"ind":"1.05"},{"date":"2026.03.17","stock":"-2.92","trade":null,"ind":"-1.87"},{"date":"2026.03.16","stock":"0.52","trade":null,"ind":"0.19"},{"date":"2026.03.13","stock":"-0.31","trade":null,"ind":"-0.65"},{"date":"2026.03.12","stock":"-0.52","trade":null,"ind":"-0.63"},{"date":"2026.03.11","stock":"-1.03","trade":null,"ind":"0.78"},{"date":"2026.03.10","stock":"3.19","trade":null,"ind":"2.04"},{"date":"2026.03.09","stock":"0.00","trade":null,"ind":"-0.74"},{"date":"2026.03.06","stock":"3.18","trade":null,"ind":"0.59"},{"date":"2026.03.05","stock":"1.90","trade":null,"ind":"1.23"},{"date":"2026.03.04","stock":"-2.93","trade":null,"ind":"-0.75"},{"date":"2026.03.03","stock":"-2.64","trade":null,"ind":"-3.07"},{"date":"2026.03.02","stock":"-6.05","trade":null,"ind":"-0.20"},{"date":"2026.02.27","stock":"1.10","trade":null,"ind":"-0.06"},{"date":"2026.02.26","stock":"0.10","trade":null,"ind":"0.19"},{"date":"2026.02.25","stock":"0.10","trade":null,"ind":"1.29"}]
易瑞生物,深证成指,医疗器械指数
压力支撑
该股压力位为8.52元，支撑位为8.37元。
[{"text":"\u538b\u529b\u4f4d","value":"8.52","date":1774368000,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"8.37","date":1774368000,"color":"0x0b52a1"}]
多空趋势
空头行情中，目前反弹趋势有所减缓，投资者可适当关注。
macd
kdj
boll
asi
bias
rsi
wr
vr
资金面诊股
诊断结果：4.1资金面打败了88%的股票
主力控盘前10的股票
行业资金
医疗器械行业， 近5日资金总体呈流出状态，请投资者谨慎关注该行业的个股。
更新时间：03月26日 08:08
| 机构今日流向(万元) | -459.17 | 机构5日流向(万元) | -3511.37 |
| 机构10日流向(万元) | -4928.10 | 机构20日流向(万元) | -10344.61 |
机构持仓
2025-06-30 与 2024-12-31 相比，主力机构持仓量增加722.42万股，其中基金净减仓2家，主力净增仓11家，请投资者中长期谨慎为宜。
截止2025-06-30，共40家主力机构（基金35家，一般法人5家），持仓量总计18672.69万股，占流通A股46.53%
其中，基金持仓与2024-12-31相比：
增仓：0家 ，增持 0万股
减仓：2家 ，减持 7.21万股
新出现在主力名单中：30家 ，持有920.3万股
从主力名单中消失：19家 ，原持有91.98万股
其中，基金持仓与2024-12-31相比：
增仓：0家 ，增持 0万股
减仓：2家 ，减持 7.21万股
新出现在主力名单中：30家 ，持有920.3万股
从主力名单中消失：19家 ，原持有91.98万股
消息面诊股
诊断结果：5.5消息面打败了43%的股票
今日有利好新闻的公司
近期该股消息面总体多空平衡，没有较强的利好或利空趋势。
更多>>个股资讯
- 易瑞生物：3月24日获融资买入689.35万元
2026-03-25 - 易瑞生物：3月19日获融资买入351.44万元
2026-03-20 - 易瑞生物：3月18日获融资买入353.49万元
2026-03-19 - 易瑞生物：3月17日获融资买入329.22万元
2026-03-18 - 易瑞生物：3月16日获融资买入531.82万元
2026-03-17 - 易瑞生物：3月13日获融资买入343.22万元
2026-03-16 - 易瑞生物：3月12日获融资买入350.86万元
2026-03-13 - 易瑞生物：3月11日获融资买入289.33万元
2026-03-12 - 易瑞生物：3月10日获融资买入558.87万元
2026-03-11 - 易瑞生物：3月9日获融资买入394.51万元
2026-03-10
消息列表
| 一般消息 | 高管变动 | 因个人原因 | 2026-02-03 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2026-02-02 |
| 一般消息 | 高管变动 | 取消监事会 | 2025-09-15 |
| 一般消息 | 股东大会 | 临时股东大会 | 2025-08-28 |
| 一般消息 | 分红转增 | 不分配不转增 | 2025-08-28 |
| 利好 | 分红转增 | 10派0.174399元(含税) | 2025-04-25 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2025-04-10 |
一年消息统计
| 所有消息 | 重大消息 | 非重大消息 | |
| 利好 | 1条 | 0条 | 1条 |
| 利空 | 0条 | 0条 | 0条 |
行业面诊股
诊断结果：0.0行业面打败了4%的股票
医疗器械行业最新资金流向
-
行业走势
[{"date":"2026.03.25","price":"1.95","value":null},{"date":"2026.03.24","price":"1.43","value":null},{"date":"2026.03.23","price":"-3.76","value":null},{"date":"2026.03.20","price":"-0.25","value":null},{"date":"2026.03.19","price":"-2.02","value":null},{"date":"2026.03.18","price":"1.05","value":null},{"date":"2026.03.17","price":"-1.87","value":null},{"date":"2026.03.16","price":"0.19","value":null},{"date":"2026.03.13","price":"-0.65","value":null},{"date":"2026.03.12","price":"-0.63","value":null},{"date":"2026.03.11","price":"0.78","value":null},{"date":"2026.03.10","price":"2.04","value":null},{"date":"2026.03.09","price":"-0.74","value":null},{"date":"2026.03.06","price":"0.59","value":null},{"date":"2026.03.05","price":"1.23","value":null},{"date":"2026.03.04","price":"-0.75","value":null},{"date":"2026.03.03","price":"-3.07","value":null},{"date":"2026.03.02","price":"-0.20","value":null},{"date":"2026.02.27","price":"-0.06","value":null},{"date":"2026.02.26","price":"0.19","value":null},{"date":"2026.02.25","price":"1.29","value":"-357279036.44"}]
深证成指,医疗器械行业
行业排名
| 排名 | 股票名称 | 1月涨跌幅 | 5日涨跌幅 | 评分 |
|---|---|---|---|---|
| 1 | 九安医疗 | 41.84% | 6.26% | 5.5分 |
| 2 | 英科医疗 | 37.53% | -6.18% | 5.1分 |
| 3 | 蓝帆医疗 | 30.18% | -1.38% | 5.3分 |
| 4 | 康拓医疗 | 24.96% | 13.44% | 5.7分 |
| 5 | 中源协和 | 17.88% | -2.43% | 4.6分 |
| 6 | 华兰股份 | 13.45% | -2.32% | 5.0分 |
| 8 | 亚辉龙 | 8.11% | -2.31% | 3.8分 |
| 10 | 奥美医疗 | 6.82% | -0.17% | 5.0分 |
| 12 | 基蛋生物 | 4.92% | -11.66% | 5.1分 |
| 14 | 心脉医疗 | 4.33% | -3.34% | 4.8分 |
| 16 | 维力医疗 | 3.82% | -0.70% | 5.7分 |
| 18 | 可孚医疗 | 2.32% | -3.41% | 5.6分 |
| 20 | 英诺特 | 1.27% | -8.14% | 3.8分 |
| 22 | 健信超导 | -0.22% | -8.27% | 5.4分 |
| 24 | 济民健康 | -1.76% | -2.41% | 4.6分 |
| 26 | 理邦仪器 | -3.75% | -7.41% | 5.7分 |
| 28 | 新产业 | -4.50% | -3.30% | 4.9分 |
| 30 | 佰仁医疗 | -4.82% | -3.01% | 4.0分 |
| 32 | 采纳股份 | -4.97% | -7.75% | 4.1分 |
| 34 | 冠昊生物 | -5.73% | -9.02% | 4.7分 |
| 36 | 圣湘生物 | -6.26% | -4.30% | 4.9分 |
| 38 | 北芯生命 | -6.75% | -8.56% | 4.8分 |
| 40 | 仁度生物 | -7.06% | -4.88% | 4.9分 |
| 42 | 力诺药包 | -7.08% | -9.66% | 4.0分 |
| 44 | 黄山胶囊 | -7.34% | -7.23% | 5.3分 |
| 46 | 伟思医疗 | -7.56% | -10.43% | 4.6分 |
| 48 | 正川股份 | -7.82% | -5.46% | 4.4分 |
| 50 | 奕瑞科技 | -7.95% | -6.36% | 4.8分 |
| 52 | 万孚生物 | -8.01% | -4.73% | 3.8分 |
| 54 | 奥泰生物 | -8.13% | -4.60% | 4.5分 |
| 56 | 尚荣医疗 | -8.27% | -7.55% | 5.1分 |
| 58 | 威高血净 | -8.28% | -6.10% | 5.7分 |
| 60 | 利德曼 | -8.71% | -6.07% | 5.1分 |
| 62 | 安图生物 | -8.79% | -4.68% | 4.4分 |
| 64 | 山东药玻 | -8.86% | -5.22% | 4.8分 |
| 66 | 阳普医疗 | -9.38% | -10.24% | 5.8分 |
| 68 | 开立医疗 | -9.67% | -6.98% | 4.5分 |
| 70 | 康德莱 | -9.75% | -9.27% | 4.6分 |
| 72 | 天益医疗 | -9.87% | -10.46% | 3.7分 |
| 74 | 东星医疗 | -9.93% | -7.42% | 4.1分 |
| 76 | 拱东医疗 | -10.37% | -6.02% | 4.5分 |
| 78 | 联影医疗 | -10.46% | -3.21% | 4.8分 |
| 80 | 浩欧博 | -10.56% | -12.60% | 4.4分 |
| 82 | - | -10.67% | -14.70% | 分 |
| 84 | 爱威科技 | -10.85% | -8.04% | 4.9分 |
| 86 | 天智航 | -11.13% | -4.22% | 3.9分 |
| 88 | 健帆生物 | -11.31% | -6.29% | 3.7分 |
| 90 | 安杰思 | -11.35% | -6.38% | 4.6分 |
| 92 | - | -11.41% | -12.47% | 分 |
| 94 | 戴维医疗 | -11.67% | -8.74% | 5.9分 |
| 96 | 乐普医疗 | -12.06% | -11.28% | 5.1分 |
| 98 | - | -12.25% | -3.93% | 分 |
| 100 | 迈普医学 | -12.37% | -1.20% | 5.5分 |
| 102 | 洁特生物 | -12.40% | -6.02% | 4.8分 |
| 104 | 山外山 | -12.43% | -4.23% | 5.2分 |
| 106 | 康泰医学 | -12.98% | -7.94% | 4.3分 |
| 108 | 西山科技 | -13.46% | -6.20% | 4.6分 |
| 110 | 三诺生物 | -13.80% | -6.78% | 4.8分 |
| 112 | 翔宇医疗 | -13.99% | -8.92% | 4.4分 |
| 114 | 热景生物 | -14.40% | -7.45% | 3.4分 |
| 116 | 易瑞生物 | -14.66% | -10.53% | 4.2分 |
| 118 | 祥生医疗 | -15.79% | -8.11% | 4.5分 |
| 120 | 福瑞医科 | -15.99% | 3.45% | 5.6分 |
| 122 | 博拓生物 | -16.28% | -9.31% | 4.1分 |
| 124 | - | -16.30% | -11.93% | 分 |
| 126 | 昊海生科 | -16.32% | -8.15% | 4.9分 |
| 128 | 天臣医疗 | -16.84% | -8.90% | 5.2分 |
| 130 | 爱博医疗 | -17.34% | -8.63% | 4.7分 |
| 132 | - | -18.29% | -6.82% | 分 |
| 134 | 东富龙 | -19.70% | -13.19% | 4.2分 |
| 136 | 美好医疗 | -21.64% | -4.75% | 5.1分 |
| 138 | - | -24.15% | -10.61% | 分 |
行业评级
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 暂无相关评级 |
更多>>行业资讯
- 2012-02-17青岛：加快向“世界强港”转型新增万吨级泊位24个
- 2012-02-17江苏港口发展“四稳四进”
- 2012-02-17今年河北省重点打造综合性港口群
- 2012-02-16招商轮船：非公开发行A股股票申请获得中国证券监督管理委员会核准
- 2012-02-16泉州市今年将冲刺“亿吨大港”
- 2012-02-16大连市集装箱运输生产“逆市飘红”
- 2012-02-16江苏港口发展“四稳四进”
- 2012-02-16连云港港：绿色生态大港正向我们走来
- 2012-02-15靖江今年港口建设预投28亿元 完成港口货物吞吐量8000万吨
- 2012-02-15舟山“大港口”建设撬动群岛新区大盘
基本面诊股
[ 截止日期：2025-09-30 ]公司经营
盈利能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 83/243 ， 44/243。
[{"date":"2025-09-30","value":"2.03","vol":"2.98"},{"date":"2025-06-30","value":"0.27","vol":"2.34"},{"date":"2025-03-31","value":"-0.39","vol":"1.16"},{"date":"2024-12-31","value":"1.99","vol":"0.56"},{"date":"2024-09-30","value":"0.46","vol":"4.64"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 净资产收 益率(%) |
2.03 | 0.27 | -0.39 | 1.99 | 0.46 |
| 行业(%) | 2.98 | 2.34 | 1.16 | 0.56 | 4.64 |
该指标值越高，盈利能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"64.30","vol":"51.74"},{"date":"2025-06-30","value":"64.47","vol":"52.05"},{"date":"2025-03-31","value":"52.37","vol":"51.42"},{"date":"2024-12-31","value":"70.63","vol":"52.52"},{"date":"2024-09-30","value":"66.09","vol":"53.36"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 销售毛利 率(%) |
64.30 | 64.47 | 52.37 | 70.63 | 66.09 |
| 行业(%) | 51.74 | 52.05 | 51.42 | 52.52 | 53.36 |
该指标值越高，盈利能力越强，行业排名越靠前。
成长能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 19/243 ， 2/243。
[{"date":"2025-09-30","value":"17.45","vol":"0.26"},{"date":"2025-06-30","value":"5.44","vol":"-1.09"},{"date":"2025-03-31","value":"35.28","vol":"-0.12"},{"date":"2024-12-31","value":"-11.75","vol":"1.15"},{"date":"2024-09-30","value":"-4.27","vol":"0.77"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 营业收入同 比增长率(%) |
17.45 | 5.44 | 35.28 | -11.75 | -4.27 |
| 行业(%) | 0.26 | -1.09 | -0.12 | 1.15 | 0.77 |
该指标值越高，成长能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"362.49","vol":"-15.37"},{"date":"2025-06-30","value":"250.02","vol":"-18.14"},{"date":"2025-03-31","value":"52.95","vol":"-2.59"},{"date":"2024-12-31","value":"109.26","vol":"-23.09"},{"date":"2024-09-30","value":"103.93","vol":"-19.92"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 净利润同比 增长率(%) |
362.49 | 250.02 | 52.95 | 109.26 | 103.93 |
| 行业(%) | -15.37 | -18.14 | -2.59 | -23.09 | -19.92 |
该指标值越高，成长能力越强，行业排名越靠前。
营运能力：一般，低于行业平均，建议投资者谨慎，两项指标的行业排名分别为 106/243 ， 70/243。
[{"date":"2025-09-30","value":"0.13","vol":"0.25"},{"date":"2025-06-30","value":"0.08","vol":"0.17"},{"date":"2025-03-31","value":"0.03","vol":"0.08"},{"date":"2024-12-31","value":"0.16","vol":"0.36"},{"date":"2024-09-30","value":"0.12","vol":"0.26"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 总资产周 转率(次) |
0.13 | 0.08 | 0.03 | 0.16 | 0.12 |
| 行业(次) | 0.25 | 0.17 | 0.08 | 0.36 | 0.26 |
该指标值越高，营运能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"1.35","vol":"1.66"},{"date":"2025-06-30","value":"0.83","vol":"1.12"},{"date":"2025-03-31","value":"0.58","vol":"0.55"},{"date":"2024-12-31","value":"1.83","vol":"2.32"},{"date":"2024-09-30","value":"1.53","vol":"1.64"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 存货增长 率(次) |
1.35 | 0.83 | 0.58 | 1.83 | 1.53 |
| 行业(次) | 1.66 | 1.12 | 0.55 | 2.32 | 1.64 |
该指标值越高，营运能力越强，行业排名越靠前。
现金流能力：数据暂时不全，请后续关注
[{"date":"2025-09-30","value":"10.28","vol":"14.74"},{"date":"2025-06-30","value":"2.33","vol":"15.17"},{"date":"2025-03-31","value":"-2.87","vol":"4.22"},{"date":"2024-12-31","value":"27.53","vol":"29.38"},{"date":"2024-09-30","value":"2.05","vol":"15.46"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 现金流量净额/营业收入 | 10.28 | 2.33 | -2.87 | 27.53 | 2.05 |
| 行业 | 14.74 | 15.17 | 4.22 | 29.38 | 15.46 |
该指标值越高，现金流能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"","vol":"0.01"},{"date":"2025-06-30","value":"1.67","vol":"1.57"},{"date":"2025-03-31","value":"","vol":"0.00"},{"date":"2024-12-31","value":"7.56","vol":"2.17"},{"date":"2024-09-30","value":"","vol":"0.01"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 资本支出／折旧和摊销 | - | 1.67 | - | 7.56 | - |
| 行业 | 0.01 | 1.57 | 0.00 | 2.17 | 0.01 |
该指标值越低，现金流能力越强，行业排名越靠前。
短期偿债能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 82/243 ， 88/243。
[{"date":"2025-09-30","value":"5.16","vol":"5.66"},{"date":"2025-06-30","value":"6.41","vol":"5.47"},{"date":"2025-03-31","value":"5.47","vol":"5.84"},{"date":"2024-12-31","value":"4.95","vol":"5.30"},{"date":"2024-09-30","value":"5.17","vol":"5.83"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 流动比率 |
5.16 | 6.41 | 5.47 | 4.95 | 5.17 |
| 行业 | 5.66 | 5.47 | 5.84 | 5.30 | 5.83 |
该指标值越接近2，短期偿债能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"4.66","vol":"4.51"},{"date":"2025-06-30","value":"5.78","vol":"4.35"},{"date":"2025-03-31","value":"5.00","vol":"4.73"},{"date":"2024-12-31","value":"4.58","vol":"4.27"},{"date":"2024-09-30","value":"4.77","vol":"4.70"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 速动比率 |
4.66 | 5.78 | 5.00 | 4.58 | 4.77 |
| 行业 | 4.51 | 4.35 | 4.73 | 4.27 | 4.70 |
该指标值越接近1，短期偿债能力越强，行业排名越靠前。
长期偿债能力：一般，低于行业平均，建议投资者谨慎，两项指标的行业排名分别为 11/243 ， 15/243。
[{"date":"2025-09-30","value":"38.55","vol":"22.07"},{"date":"2025-06-30","value":"39.06","vol":"22.01"},{"date":"2025-03-31","value":"39.97","vol":"21.19"},{"date":"2024-12-31","value":"40.28","vol":"21.94"},{"date":"2024-09-30","value":"38.08","vol":"20.60"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 资产负债 率(%) |
38.55 | 39.06 | 39.97 | 40.28 | 38.08 |
| 行业(%) | 22.07 | 22.01 | 21.19 | 21.94 | 20.60 |
该指标值越接近50%，长期偿债能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"0.63","vol":"0.71"},{"date":"2025-06-30","value":"0.64","vol":"0.58"},{"date":"2025-03-31","value":"0.67","vol":"0.56"},{"date":"2024-12-31","value":"0.68","vol":"0.55"},{"date":"2024-09-30","value":"0.62","vol":"0.37"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 产权比率 (%) |
0.63 | 0.64 | 0.67 | 0.68 | 0.62 |
| 行业(%) | 0.71 | 0.58 | 0.56 | 0.55 | 0.37 |
该指标值越高，长期偿债能力越强，行业排名越靠前。
机构预测
机构预测该股2025年每股收益与前一年相同，长期投资价值一般。
[{"date":"2021","yellowRectValue":"2.37","blueLineValue":"","type":""},{"date":"2022","yellowRectValue":"0.83","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"-1.85","blueLineValue":"","type":""},{"date":"2024","yellowRectValue":"0.17","blueLineValue":"","type":""},{"date":"2025","yellowRectValue":"0.25","blueLineValue":"0.06","type":"YC"}]